These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36302780)

  • 1. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Daoudi K; Das B; Tykalova T; Klempir J; Rusz J
    NPJ Parkinsons Dis; 2022 Oct; 8(1):142. PubMed ID: 36302780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.
    Rusz J; Tykalová T; Salerno G; Bancone S; Scarpelli J; Pellecchia MT
    J Neurol; 2019 Jun; 266(6):1394-1404. PubMed ID: 30859316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
    Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
    Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Skrabal D; Tykalova T; Klempir J; Ruzicka E; Rusz J
    J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.
    Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C
    Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
    Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
    Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
    Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy.
    Hu WZ; Cao LX; Yin JH; Zhao XS; Piao YS; Gu WH; Ma JH; Wan ZR; Huang Y
    Front Neurol; 2022; 13():1081219. PubMed ID: 36756345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing speech dysfunction using BOLD and acoustic analysis in parkinsonism.
    Saxena M; Behari M; Kumaran SS; Goyal V; Narang V
    Parkinsonism Relat Disord; 2014 Aug; 20(8):855-61. PubMed ID: 24857769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease.
    Nguyen TT; Cheng JS; Chen YL; Lin YC; Tsai CC; Lu CS; Weng YH; Wu YM; Hoang NT; Wang JJ
    Front Aging Neurosci; 2021; 13():625874. PubMed ID: 33815089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parkinsonism-associated speech disorders].
    Skripkina NA; Arefyeva AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10. Vyp. 2):61-66. PubMed ID: 33205932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction.
    Rusz J; Hlavnička J; Čmejla R; Růžička E
    Front Bioeng Biotechnol; 2015; 3():104. PubMed ID: 26258122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.